Board MeetingOutcome of Board Meeting
Camlin Fine Sciences' board approved the financial results for the quarter and half-year, reporting a consolidated loss of ₹25.63 Cr on revenues of ₹883.38 Cr.
Camlin Fine Sciences LimitedCAMLINFINE · Filed with the exchange
Key decisions include re-appointing an Independent Director, subject to shareholder approval, and granting 16.23 lakh employee stock options.
No comments yet. Be the first.